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Abstract
Background: The use of the electronic medical record (EMR) system in recruitment in clinical trials has the
potential for providing a very reliable and cost-effective recruiting methodology which may improve participant
recruitment in clinical trials. We examined a recruitment approach centered on the use of the EMR, as well as
other traditional methods, in the Lifestyle Intervention for Treatment of Diabetes (LIFT Diabetes) trial.
Methods: LIFT Diabetes is a randomized controlled trial designed to investigate the effects of two contrasting
interventions on cardiovascular disease risk: a community-based intensive lifestyle program aimed at achieving
weight loss and a clinic-based enhanced diabetes self-management program. Eligible participants were overweight/
obese (body mass index, BMI ≥25 kg/m2) patients with type 2 diabetes who were aged 21 years or older. Recruitment
strategies included the use of the EMR system (primary), direct referrals, media advertisements, and community
screenings.
Results: A total of 1102 telephone screens were conducted, resulting in randomization of 260 participants (61.5 %
from EMR, mean age 56.3 years, 66.2 % women, 48.1 % non-Hispanic blacks) over a 21-month period, with a yield of
23.6 %. Recruitment yields differed by recruitment method, with referrals having the highest yield (27.5 %). A history
of cardiovascular disease was the main health reason for exclusion from the study (16.5 %). An additional 8.9 % were
excluded for BMI <25 kg/m2 (<27 kg/m2 for insulin users), 5.4 % could not exercise, 5.2 % had an HbA1c >11 %,
and 34.9 % were excluded for other non-medical reasons. Exclusion criteria did not appear to differentially affect
enrollment in terms of race or ethnicity.
Conclusions: Future clinical studies should tailor their recruitment strategies based on the participant
demographics of interest. Efficient methods such as using the EMR system and referrals should be prioritized
over labor-intensive, low-yielding methods such as community screenings and mass mailings.
Trial registration: ClinicalTrials.gov: NCT01806727. Registered on 5 March 2013.
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Background
Recruitment of participants in clinical trials generally
falls behind schedule in up to 86 % of all trials, with
13 % of trials behind by more than 6 months [1]. Early
success in recruiting is a reliable predictor of the likeli-
hood of completing a clinical trial [2]. The use of patient
registries and databases to effectively recruit participants
for clinical trials has increased in recent years [3–6]. The
use of electronic medical records (EMRs) may improve
participant recruitment by providing an efficient method
for prescreening individuals based on predefined inclu-
sion/exclusion criteria [7, 8]. In one community weight
loss lifestyle trial which used almost exclusively medical
record review to recruit overweight adults with diabetes,
the recruitment yield was 21.5 % [4].
Barriers to the enrollment of participants in clinical
trials include factors related to healthcare providers, such
as a lack of interest in and knowledge about the trial, phys-
ician bias about the therapy under investigation, and con-
cerns about losing the patient to follow-up [9]. Factors
related to participants can also affect enrollment [10]. For
example, exclusion criteria that are too stringent may differ-
entially affect enrollment of particular race/ethnic groups.
The purpose of this report is to (1) compare the re-
cruitment yield from the use of the EMR system versus
traditional recruitment methods for the LIFT Diabetes
trial, (2) evaluate the direct cost of recruitment, and (3)
examine the differential effects of screening exclusion




The LIFT Diabetes randomized trial was designed to inves-
tigate the effects of two contrasting interventions (a 12-
month community-based intensive lifestyle intervention
versus a clinic-based enhanced diabetes self-management
program) on cardiovascular disease (CVD) risk in over-
weight and obese adults with type 2 diabetes [11, 12].
The trial protocol was approved by the Institutional
Review Board (IRB) of the Wake Forest School of
Medicine, and a limited temporary waiver of the Health In-
surance Portability and Accountability Act (HIPAA) [13]
authorization was issued by the IRB, which permitted study
investigators to access protected health information to con-
firm eligibility and facilitate initial contact for recruitment
as allowed by government regulations. All participants in
the study gave a verbal consent before the telephone screen
and a written informed consent at their initial screening
visit.
Study eligibility
Participants eligible for recruitment into the LIFT
Diabetes trial were aged 21 or older, had a confirmed
diagnosis of type 2 diabetes (HbA1c ≥6.5 %, a physician
diagnosis of diabetes on the participant’s problem list, or
the use of diabetes medication), a body mass index (BMI)
of 25 or greater (27 or greater if on insulin), and a regular
source of medical care. Participants were excluded be-
cause of the following: history of prior cardiovascular dis-
ease or history of cancer with expected survival less than
2 years; glycosylated hemoglobin (HbA1c) >11 %, blood
pressure >160/100 mmHg, triglycerides >600 mg/dl; his-
tory of prior weight loss surgery; unstable psychiatric dis-
ease; inability to walk two blocks without stopping; drug
or alcohol abuse; use of drugs known to affect body weight
(e.g., corticosteroids); pregnancy or breastfeeding; and ad-
vanced renal disease (estimated glomerular filtration rate,
eGFR <45 ml/min/1.73 m2).
Recruitment methods
The LIFT Diabetes trial aimed to recruit a sample of
55–60 % African American, 10–15 % Hispanic, and 25–
35 % non-Hispanic White (NHW) participants. The trial
recruited 260 participants in Winston-Salem, North
Carolina, USA and surrounding areas.
The primary recruitment method employed was the
use of the EMR system and targeted mailing. Individuals
with a diagnosis of diabetes mellitus on the problem list
in their medical records were identified via an EMR sys-
tem containing records for Wake Forest Baptist Health
(WFBH) patients. These individuals were then initially
screened electronically (e-screening) for major exclusions
(history of CVD, cancer, prior weight surgery) cited on the
problem list. During this initial e-screening phase, a less
strict cut-off value was used for clinical and biological pa-
rameters such as BMI, blood pressure, HbA1c, triglycerides,
and eGFR, since these measurements can change signifi-
cantly over time. For example, for blood pressure, a systolic
pressure of 170 mmHg and/or a diastolic pressure of 110
was used for e-screening, in place of the predefined cut-off
of >160/100 mmHg. Individuals remaining potentially eli-
gible were mailed a brochure with an opt-out postcard to
return if not interested. If a postcard was not received after
2 weeks, a study staff member reached out to potential par-
ticipants to determine interest and conduct a telephone
screen. To assess the efficacy of the EMR as a screening
tool, sensitivity and specificity analyses were done on a
random subsample of participants with diabetes on the
problem list.
Another recruitment method used was direct referrals
from physicians or other healthcare providers, study par-
ticipants, and study team members. To foster referrals
from within the WFBH system, several study investiga-
tors made presentations at Internal Medicine and Family
Medicine faculty meetings. For healthcare provider refer-
rals, LIFT Diabetes contact cards were made available for
interested individuals to provide their contact information.
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Study team members attended six health screening
events in the community (health fairs and church
screenings), where interested participants were either
screened on site or contacted at a later date by tele-
phone. The study team also distributed flyers in targeted
local pharmacies in the community and different WFBH
medical practices. In order to increase the representation
of African Americans in the trial, especially African
American men, television advertisements were aired
during specific programs and specific times of the day,
and a study investigator completed a radio interview.
LIFT Diabetes study advertisements were also printed
and published in a local newspaper and magazine and in
church bulletins, and posted online (on the Wake Forest
Baptist Health website for clinical studies and an online
press). All study recruitment materials were approved by
the IRB of the Wake Forest School of Medicine and
focused on three main criteria: adults aged 21 and
older, a diagnosis of type 2 diabetes, and being overweight
or obese.
Participant screening and randomization
Participants who expressed interest in the study were
screened either via telephone or face to face using a
scripted screening instrument. Five telephone screening
calls were attempted for each participant who did not
opt out, and a voicemail message requesting a return call
was recorded whenever possible. To determine potential
eligibility during the phone screen, major exclusions were
assessed. A typical telephone screen lasted on average
15 min. For most participants, eligibility to progress to the
next screening phase was established during the telephone
interview. For a few, a second review by the study phys-
ician was required.
All participants deemed potentially eligible after the
telephone screen were invited to attend a clinic where
additional screening was performed to assess final eligibility.
During the clinic visit, the following eligibility parameters
were assessed: confirmed diagnosis of diabetes, blood
pressure ≤160/100 mmHg, BMI ≥25 kg/m2, urine (dipstick
analysis) proteinuria <4+, HbA1c ≤11 %, eGFR ≥45 ml/
min, triglycerides ≤600 mg/dl, absence of a history of CVD,
ability to exercise (using the Physical Activity Readiness
Questionnaire), and absence of severe depression (using the
Patient Health Questionnaire - 9 instrument). Participants
who remained eligible after the first clinic screening visit
were invited to a baseline visit, during which they were ran-
domized to one of the two arms of the trial. The duration
of recruitment and randomization was dependent on the
number of personnel, the duration of clinic visits, and the
willingness of eligible individuals to participate. Of note, we
aimed to recruit participants in waves, as we were limited
to a maximum of six concurrent groups due to staffing and
space constraints.
Estimation of recruitment time
Personnel effort was estimated using full-time equiva-
lents (FTEs) for all persons involved with recruitment.
An FTE was estimated based on the percentage effort al-
located to the activity of recruitment. For example, an
FTE of 1.0 was equivalent to a 100 % effort, which trans-
lated to 40 h of work per week by the personnel. The
number of persons directly involved with recruitment
was not constant throughout the entire period, and as
such personnel effort was estimated on a monthly basis.
The actual amount of time (in hours) spent by personnel
during recruitment was estimated. Estimates were done
for the telephone screening encounter as well as both
clinic visits. For the telephone screening encounters, the
estimated time included the time to obtain a verbal con-
sent, complete the screening questionnaire, and enter
the data into the online database system. For both clinic
visits (eligibility screen and baseline), the estimated time
included the time to obtain a written consent, complete
all relevant forms, and enter the data into the online
database system.
Statistical analyses
Results are presented as mean and standard deviation
or number (percentage) where appropriate. Differences
in demographic and clinical variables between enrolled
and non-enrolled participants were assessed using the
Kruskal-Wallis test for continuous variables and the
chi-square or Fisher’s exact test (where cell counts are
low) for categorical variables. The estimate for the overall
recruitment yield was calculated as the ratio of partici-
pants enrolled in the study to the total number of partici-
pants reached by telephone. The recruitment yield was
also estimated per recruitment method and by race/ethnic
group. (The cumulative number of participants random-
ized against the study goal is plotted in Fig. 2.) To test if
exclusion criteria differentially affected enrollment of Afri-
can Americans, logistic regression models were fitted to
estimate odds ratios for African Americans compared to
other race/ethnic groups (as the reference) for each of the
major criteria. For this analysis, 41 participants were
excluded because they had missing data on race. A P
value of less than 0.05 was considered statistically signifi-
cant. All analyses were performed using SAS version 9.3
(SAS Institute Inc., Cary, NC).
Results
Recruitment stages
Recruitment efforts began in May 2013 and were con-
cluded by the first week in March 2015. A total of 260
participants were randomized over a 21-month period
(June 2013 to March 2015). The recruitment process
was completed in four phases. In the first phase, a total
of 5122 unique medical records (after duplicate records
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had been eliminated) were abstracted from the EMR
database and assessed for major exclusions. After this
initial assessment, 2767 EMR records were retained
for a telephone screen. An additional 465 telephone
screen-eligible participants came from direct referrals,
media advertisements, community screening events,
and other sources (Fig. 1). In the second phase, 1102
(64.8 % from EMR) participants contacted completed
a telephone screen (a total of 6899 phone calls were
made, including missed calls), of which 593 (53.8 %)
qualified for a clinic screening visit (third phase of recruit-
ment). Of the 593 potential participants, 289 were declared
eligible for a baseline visit and eventual randomization.
In the last phase of recruitment (randomization phase),
260 (61.5 % from EMR) participants were randomized
(130 in each arm of the study). Figure 2 displays the cu-
mulative number of participants randomized versus the
study goal.
Characteristics of excluded participants
Among all individuals reached by telephone for an initial
screen, 842 (76.4 %) were excluded from the study. At
the level of the telephone screen, compared to enrolled
participants, a higher percentage of non-Hispanic blacks
(NHB) were excluded (57.3 versus 48.1 %, P = 0.01) (see
Table 1). More non-Hispanic whites (NHW) were enrolled
than excluded at this stage of screening (45.4 versus
34.1 %). At the level of the clinic screening visit, compared
to those who enrolled, excluded individuals were signifi-
cantly younger, and a lower percentage were on medica-
tions for diabetes, hypertension, and dyslipidemia (Table 1).
There were no differences in sex, BMI, HbA1c, duration of
diabetes, blood pressure, or smoking status between
enrolled participants and those excluded.
Table 2 illustrates the reasons for exclusion of individ-
uals during the LIFT Diabetes screening process. The
major health reason for exclusion was a history of CVD
Fig. 1 Flowchart of the recruitment process for the LIFT Diabetes trial. Community screenings refers to screenings during health and church fairs.
Media refers to television, radio, and print advertisements. Referrals were from healthcare providers, study staff, participants’ friends and relatives,
and other studies. Unknown/other refers to participants whose source of recruitment was either unknown or from the Wake Forest Be Involved
website, ClinicalTrials.gov website, and other online advertisement. DSM diabetes self-management, LWL lifestyle weight loss
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or cardiovascular procedure (16.5 % of participants). A
BMI <25 kg/m2 (<27 kg/m2 for insulin users) and an
HbA1c > 11 % accounted for more than 8.9 and 5.2 % of
exclusions, respectively. About 5.4 % of those screened
reported being unable to exercise. In multivariable logistic
regression analysis, compared to other race/ethnic groups,
NHB were not more likely to be excluded from the study
because of predefined criteria (Additional file 1: Table S1).
Recruitment yield by race/ethnicity and by recruitment
method
Overall, the recruitment yield was 23.6 %. The yield was
higher for NHW (30.2 %), compared to NHB (21.4 %)
and Hispanics (20 %). When recruitment methods were
compared, the yield was highest for referrals (27.5 %).
The yield for participants recruited through the EMR was
22.4 %, higher than that for community screening events
(13.6 %) and media advertisements (20.5 %) (Fig. 3a).
Randomized participants by race/ethnicity and by
recruitment method
Overall, 61.5 % of randomized participants were re-
cruited through the EMR system, compared to 25.4 %
recruited through direct referrals. About two-thirds of
all participants recruited via referrals were NHB. A smaller
percentage of randomized participants were recruited
through media advertisements (5.8 %), health and church
screening events (1.2 %), and other methods (6.1 %).
Figure 3b displays the percent of randomized participants
by recruitment method and by race/ethnicity. There
was a significance difference in proportions of NHW,
NHB, and other race/ethnic groups by the recruitment
methods (P < 0.0001). About three-quarters (72.9 %) of
randomized NHW were recruited through the EMR,
compared to 49.6 % of randomized NHB (Fig. 3b). In
comparison, 32.8 and 10.4 % of randomized NHB, ver-
sus 18.6 and 1.7 % of randomized NHW, were recruited
through direct referrals and media advertisements,
respectively.
Estimation of recruitment time
Average monthly personnel effort throughout the recruit-
ment period ranged from 0.613 to 0.825 FTE per week
(24.5–33.0 h per week) per personnel. The average time
spent to complete a telephone screen was 0.5 h (30 min). A
total of 1102 telephone screens were completed, which
amounts to an average of 551 h. Clinic visits lasted on aver-
age 2 h each. There were a total of 478 completed eligibility
screening visits and 281 completed baseline visits. The total
time spent for both clinic visits averaged 1518 h. Per re-
cruited participant, the average time spent was 4.5 h.
For the 2130 uncompleted telephone screens (either
due to a nonresponse to the telephone call or because
the participant expressed no interest in participating),
each encounter attempt lasted on average 5 min or less.
These time estimates do not take into account the time
spent for unanswered telephone call attempts, telephone
calls to schedule clinic appointments, and time spent de-
signing brochures/flyers and media advertisements.
Sensitivity analysis
On a random subsample of participants (n = 200, 27 %
African Americans), the sensitivity and specificity of the
EMR as a screening tool were assessed. Eligibility of
Fig. 2 Cumulative number of participants randomized versus the study goal in the LIFT Diabetes trial (period from June 2013 to March 2015). The
solid line represents the study goal, while the dashed line is a plot of the actual number randomized for the study
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participants based on the EMR was checked against eli-
gibility based on a manual review of patients’ medical
charts. The sensitivity of the EMR was estimated at
45.3 % and its specificity at 91.2 %.
Discussion
The goal of recruitment for the LIFT Diabetes trial was
to enroll 260 participants, including a target for minority
groups higher than that of previous similar trials (55–60 %
NHB and 10–15 % Hispanics). Using the EMR as the
primary method of recruitment, the recruitment goal
was achieved within close to the prespecified time
period (recruitment was extended by one week). Our
analysis also revealed a recruitment yield of more than
24 % and a total direct cost of $821 to randomize each en-
rolled participant. The main medical reasons for exclusion
Table 1 Demographic and clinical characteristics of LIFT Diabetes participants by enrollment status
Characteristic Total screened participants Non-enrolled participants Enrolled participants P value
Phone screen eligible, N 1102 842 260
Age, years 55.0 ± 11.6 54.7 ± 11.8 56.3 ± 10.7 0.054
Female, n (%) 674 (62.9) 502 (61.8) 172 (66.2) 0.21
Race/ethnicity 0.012
Non-Hispanic black 584 (55.0) 459 (57.3) 125 (48.1)
Non-Hispanic white 391 (36.9) 273 (34.1) 118 (45.4)
Hispanic 31 (2.9) 25 (3.1) 6 (2.3)
Other (NA, AN, AI, Asian, PI) 55 (5.2) 44 (5.5) 11 (4.2)
Screening visit eligible, N 407 147 260
Age, years 55.3 ± 10.7 53.7 ± 10.3 56.3 ± 10.7 0.033
Female, n (%) 264 (64.9) 92 (62.6) 172 (66.2) 0.47
Race/ethnicity 0.054
Non-Hispanic black 206 (50.6) 81 (55.1) 125 (48.1)
Non-Hispanic white 168 (41.3) 50 (34.0) 118 (45.4)
Hispanic 15 (3.7) 9 (6.1) 6 (2.3)
Other (NA, AN, AI, Asian, PI) 18 (4.4) 7 (4.8) 11 (4.2)
Smoking status, n (%) 0.44
Current 67 (16.8) 27 (19.4) 40 (15.4)
Former 125 (31.3) 39 (28.1) 86 (33.1)
Never 207 (51.9) 73 (52.5) 134 (51.5)
Body mass index, kg/m2 38.1 ± 8.8 38.7 ± 9.3 37.8 ± 8.5 0.33
Body mass index categories, kg/m2 0.65
25–29.9 74 (18.3) 24 (16.7) 50 (19.2)
30–34.9 125 (30.9) 41 (28.5) 84 (32.3)
35–39.9 88 (21.8) 35 (24.3) 53 (20.4)
≥ 40 117 (29.0) 44 (30.6) 73 (28.1)
Diabetes medication use, n (%) 325 (79.9) 100 (68.0) 225 (86.5) <0.0001
Hypertension medication use, n (%) 303 (74.5) 94 (63.9) 209 (80.4) <0.001
Lipid-lowering medication use, n (%) 208 (51.1) 60 (40.8) 148 (56.9) 0.002
HbA1c 7.8 ± 1.7 8.1 ± 2.1 7.6 ± 1.3 0.57
Duration of diabetes, years 8.6 ± 8.0 8.8 ± 8.5 8.5 ± 7.8 0.99
Estimated GFR, ml/min/1.73 m2 92.4 ± 22.2 93 ± 22 92.1 ± 22.3 0.23
Systolic blood pressure, mmHg 127.1 ± 16.7 128.6 ± 18.4 126.3 ± 15.7 0.37
Diastolic blood pressure, mmHg 77.0 ± 10.4 78.8 ± 10.3 76.1 ± 10.3 0.046
Triglycerides, mg/dl 169.8 ± 106.0 172.3 ± 114.2 168.5 ± 101.7 0.88
Data are mean ± SD or number (percentage)
AI American Indian, AN Alaskan native, GFR glomerular filtration rate, NA Native American, PI Pacific Islander
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were a history of CVD or cardiovascular procedure and a
BMI <25 kg/m2.
Our recruitment period of 21 months (approximately
12 participants randomized per month) is consistent
with recruitment in other lifestyle intervention studies.
In Healthy Living Partnerships to Prevent Diabetes
(HELP PD) and the multisite Lifestyle Interventions and
Independence for Elders (LIFE) Study, over a 21-month
period, 301 participants (14/month) and 1635 elderly
participants (10/month) were enrolled, respectively [14,
15]. Similarly, the multisite Look AHEAD (Action for
Health in Diabetes) trial enrolled 5145 participants (10/
month) over a period of 33 months [16, 17]. Although
our recruitment rate was consistent with these studies,
comparisons across studies can be challenging due to
differences in recruitment goals and resources.
Overall, 23.6 % of all participants screened were en-
rolled into the study. The recruitment yield was higher
for NHW (30.2 %) than for NHB (21.4 %) and Hispanics
(20 %). Prior studies have reported lower recruitment
yields ranging from 2.4–17.9 % [14, 15, 17–19]. In all of
these studies, only traditional recruitment methods were
used, including direct mass mailings. In LIFT Diabetes,
the use of the EMR and e-screening permitted targeted
mailing to only potentially eligible individuals for a tele-
phone screen, thus increasing the overall yield. Similar
to our finding, Parra-Medina D et al. recruited 189
participants into a weight management trial almost ex-
clusively by medical record review and achieved a recruit-
ment yield of 21.5 % [4]. We also observed a higher
recruitment yield for African Americans in LIFT Diabetes
compared to what was reported in Look AHEAD (21.4 %
versus 12.9 %) [17].
The recruitment yield for the EMR was 22.4 %, con-
sistent with the literature, which shows that recruitment
using databases and patient registries tends to be more
efficient than other methods [20]. More than two-thirds
(61.5 %) of enrolled participants were drawn from the
EMR, higher than that reported by direct mass mailings
in the Diabetes Prevention Program (DPP) (29 %) and








Non-diabetic 15 (1.9 %) 5 (1.1 %) 10 (2.9 %) 0.07
Under 25 and always on insulin 7 (0.9 %) 7 (1.5 %) 0 (0 %) 0.02
BMI <25 kg/m2 or <27 kg/m2 for insulin users 71 (8.9 %) 42 (9.2 %) 29 (8.5 %) 0.80
History of CVD or cardiovascular procedure* 132 (16.5 %) 70 (15.3 %) 62 (18.1 %) 0.29
Alcohol (>14 drinks for men aged 65 years or less, > 7 drinks
for men and women aged over 65 years) or drug abuse
11 (1.4 %) 2 (0.4 %) 9 (2.6 %) 0.01
Other medical conditions (including chronic disease,
leg amputation, blood clot, IBD, Crohn’s disease, acromegaly)
43 (5.4 %) 31 (6.8 %) 12 (3.5 %) 0.06
Prior weight loss surgery 19 (2.4 %) 12 (2.6 %) 7 (2 %) 0.65
History of cancer 4 (0.5 %) 2 (0.4 %) 2 (0.6 %) 1.00
Unable to exercise 43 (5.4 %) 29 (6.3 %) 14 (4.1 %) 0.21
Use of steroid pills or shots 33 (4.1 %) 18 (3.9 %) 15 (4.4 %) 0.86
Unwilling to stop weight loss medications/program 13 (1.6 %) 6 (1.3 %) 7 (2 %) 0.42
Pregnancy, breastfeeding 6 (0.7 %) 5 (1.1 %) 1 (0.3 %) 0.25
Hospitalized depression/PHQ-9 11 (1.4 %) 3 (0.7 %) 8 (2.3 %) 0.06
Physician review includes PAR-Q 53 (6.6 %) 31 (6.8 %) 22 (6.4 %) 0.89
Blood pressure ≥160/100 mmHg 8 (1.0 %) 5 (1.1 %) 3 (0.9 %) 1.00
HbA1c ≥11 % 42 (5.2 %) 25 (5.4 %) 17 (5 %) 0.87
Laboratory exclusions (GFR <45, triglycerides >600) 10 (1.2 %) 3 (0.7 %) 7 (2 %) 0.11
Other reasons (household member works for LIFT, cannot
commit to travel, another research study, schedule conflict,
no PCP, needs sign language interpreter, ineligible with no
reason given)
109 (13.6 %) 59 (12.9 %) 50 (14.6 %) 0.47
Decided not to participate/no show 171 (21.3 %) 104 (22.7 %) 67 (19.6 %) 0.34
*Includes: MI, stroke, TIA, coronary bypass surgery, coronary angioplasty, heart balloon surgery, stenting, and cardiac rehabilitation
BMI body mass index, CVD cardiovascular disease, GFR glomerular filtration rate, HbA1c glycosylated hemoglobin, IBD inflammatory bowel disease, MI myocardial
infarction, PAR-Q physical activity readiness questionnaire, PCP primary care physician, PHQ-9 patient health questionnaire, TIA transient ischemic attack
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LIFE Study (57.9 %) [15]. The higher percentage ob-
served with the EMR may be due to the initial e-screen,
which yielded a narrow pool of potentially eligible par-
ticipants for targeted mailings. Average monthly
personnel effort throughout the recruitment period
ranged from 0.613 to 0.825 FTE per week (24.5–33.0 h
per week) per personnel. The total time spent to recruit
and randomize each participant was on average 4.5 h.
The most challenging aspect of recruitment was enrolling
a representative sample of African Americans, especially
men. We found referrals and media advertisements to be
effective strategies in addressing this challenge. This is con-
sistent with prior research which shows that recruitment
strategies using previous relationships and interpersonal ap-
proaches such as provider or healthcare professional refer-
rals are generally efficient and effective in recruiting
minorities [21, 22]. Our sample comprised 48 % NHB, 33 %
of whom were drawn from direct referrals. In an effort to
increase the representation of NHB, targeted radio and TV
advertisements were aired during the last quarter of the re-
cruitment window. Of the 15 participants recruited via
media advertisements, 13 (86.7 %) were NHB. Participants
had to be fluent in the English language, since all study ma-
terials and the interventions were conducted exclusively in
English. As such, a majority of Hispanics were excluded
from the study.
Recruitment via community health screening events
had the lowest yield of all methods. In addition, these
community screenings were very labor-intensive and ex-
pensive; only three participants were enrolled via this
method, yet the cost to randomize one participant was
more than double that of the EMR. Community screen-
ings have been identified as the least successful of re-
cruitment strategies in other similar clinical studies [18],
suggesting that these should not be used as a primary
strategy.
Fig. 3 a Recruitment percent yield. b Percentage of participants enrolled. Data are presented by recruitment method. The horizontal axis displays
the different recruitment methods. The numbers on the bars indicate the actual number of participants enrolled for each method. Community
screening refers to screenings during health and church fairs. Media refers to television, radio, and print advertisements. Referrals were from
healthcare providers, study staff, participants’ friends and relatives, and other studies. Unknown/other refers to participants whose source of
recruitment was either unknown or from the Wake Forest Be Involved website, ClinicalTrials.gov website, and other online advertisement.
AA African American, EMR electronic medical record
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Despite the efficiency and cost-effectiveness of the EMR
method, there are a number of limitations to using this ap-
proach. First, because the EMR was our primary recruit-
ment method, we may have targeted mainly patients with
type 2 diabetes who use the WFBH clinical centers as their
source of care. The potential for this is however reduced,
as slightly more than a third of our final sample came
from methods other than the EMR. Also, WFBH has sev-
eral clinics in Forsyth County and serves a significant pro-
portion of the population. Second, the success of the EMR
method is dependent on a proper medical coding system.
Improper diagnosis coding may lead to misclassification,
which can reduce the efficiency of the process. The EMR
system used at the WFBH clinical centers allows the tag-
ging of specific diagnosis codes, which makes e-screening
feasible. Third, because the EMR system is not standard-
ized across hospitals and clinical research sites, compari-
sons of EMR use in recruitment across studies can be
challenging. Finally, the use of EMR for recruiting may
miss potential participants who are underserved and have
limited access to the healthcare system.
Conclusions
Findings from the recruitment process in the LIFT Dia-
betes trial demonstrate that the EMR is an efficient tool
which should be considered as a primary recruitment
method for future clinical trials. Our results also show that
the EMR approach should be used in combination with
other recruitment strategies with proven efficacy in minor-
ity groups, such as direct referrals and media advertise-
ments, as this can remarkably increase the recruitment
yield for these groups. Future clinical studies will need to
tailor their recruitment strategies based on the participant
demographics of interest. Efficient methods with modest
yields such as the EMR, direct referrals, and media adver-
tisements should be prioritized over labor-intensive, low-
yielding methods such as community screenings.
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